Home Cart Sign in  
Chemical Structure| 107233-08-9 Chemical Structure| 107233-08-9

Structure of Cevimeline
CAS No.: 107233-08-9

Chemical Structure| 107233-08-9

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Cevimeline is a parasympathomimetic and muscarinic agonist, with particular effect on M3 receptors and used in the treatment of dry mouth associated with sjogren's syndrome.

Synonyms: AF102B

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Cevimeline

CAS No. :107233-08-9
Formula : C10H17NOS
M.W : 199.31
SMILES Code : C[C@H]1SC[C@@]2(CN3CCC2CC3)O1
Synonyms :
AF102B
MDL No. :MFCD22577792

Safety of Cevimeline

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT01690052 Dry Mouth Not Applicable Completed - United States, Kentucky ... More >> University of Kentucky Orofacial Pain Center College of Dentistry Lexington, Kentucky, United States, 40536 Less <<
NCT01552681 - Terminated(Expired experimenta... More >>l study agent, no additional supply available.) Less << - -
NCT01690052 - Completed - -
NCT01552681 Primary Sj?gren's Syndrome Phase 2 Terminated(Expired experimenta... More >>l study agent, no additional supply available.) Less << - United States, California ... More >> Cedars-Sinai Medical Center Los Angeles, California, United States, 90048 Stanford University Palo Alto, California, United States, 94304 United States, Connecticut St. Francis Hospital and Medical Center Hartford, Connecticut, United States, 06105 United States, Illinois University of Chicago Chicago, Illinois, United States, 60637 United States, Maryland Johns Hopkins Medical Institute Baltimore, Maryland, United States, 21224 United States, New York University of Rochester Medical Center Rochester, New York, United States, 14642 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Oklahoma Oklahoma Medical Research Foundation Oklahoma City, Oklahoma, United States, 73104 United States, Pennsylvania University of Pittsburgh Pittsburgh, Pennsylvania, United States, 15260 Less <<
NCT00017511 Head and Neck Cancer ... More >> Oral Complications Radiation Toxicity Less << Phase 3 Completed - -
NCT00466388 Xerostomia Phase 4 Completed - United States, Colorado ... More >> Colorado Springs, Colorado, United States United States, Illinois Carle Clinic Association Urbana, Illinois, United States, 61801 United States, Kansas University of Kansas Medical Center Kansas City, Kansas, United States, 66160 United States, Kentucky Commonwealth Ear, Nose and Throat Louisville, Kentucky, United States, 40207 United States, Pennsylvania Associated Otolaryngologist Palmyra, Pennsylvania, United States, 17078 University of Pittsburgh Pittsburgh, Pennsylvania, United States, 15213 United States, Virginia Fauquier ENT Consultants Warrenton, Virginia, United States, 20186 Less <<
NCT01903122 Dry Mouth Early Phase 1 Completed - United States, Nevada ... More >> Novum Pharmaceutical Research Services Las Vegas, Nevada, United States, 89121 Less <<
NCT01903109 Dry Mouth Early Phase 1 Completed - United States, Nevada ... More >> Novum Pharmaceutical Research Services Las Vegas, Nevada, United States, 89121 Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

5.02mL

1.00mL

0.50mL

25.09mL

5.02mL

2.51mL

50.17mL

10.03mL

5.02mL

References

 

Historical Records

Categories